Here you will find all MLL news as well as scientific contributions to leukemia diagnostics and research

Current articles

Dr. rer. nat. Sabine Jeromin
from 16.11.2019
Standardization of the BCR-ABL1 Quantification in CML

When using molecular tests to quantify BCR-ABL1 in CML patients, it is recommended that the test be performed in a standardized laboratory. Standardization ensures that results comply with the ELN (European LeukemiaNet; Baccarani et al., Blood 2013) guidelines, enables comparisons to be made between laboratories and serves as quality assurance.

Dr. med. Christian Pohlkamp
from 18.11.2019
MLL News
MLL develops an interactive PDF version of the test request form.

Our understanding of the genetic changes underpinning malignant disease has expanded tremendously in the past few years. This is also reflected in the increasingly complex diagnostics on offer, particularly in the field of molecular genetics.

Dr. med. Richard Schabath
from 01.11.2019
Additional molecular genetic diagnostics for multiple myeloma

Approx. 10% of all hematological neoplasias are plasma cell diseases such as multiple myeloma (MM) or plasma cell leukemias. As is the case for other hematological diseases, molecular genetic diagnostics can be viewed as increasingly relevant in the diagnosis, prognosis and therapeutic stratification of MM.

Dr. rer. nat. Ines Schmidts
from 23.10.2019
The importance of advanced molecular diagnostics in cytopenia and (suspected) MDS

Next-generation sequencing (NGS) has rapidly become an indispensable tool in diagnostic molecular genetics. A recent article in Blood (Steensma Blood 2018) examined how patients with ambiguous cytopenia or with a (suspected) MDS diagnosis can benefit from the diagnostic potential of NGS.

Newsletter registration

Sign up for our MLL News and receive information on latest findings in leukemia diagnostics and research. Newsletter only available in German.
Sign up now